Medivir AB (LTS:0GP7)
kr 2.73 -0.19669 (-6.72%) Market Cap: 302.85 Mil Enterprise Value: 146.87 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 58/100

Q2 2021 Medivir AB Earnings Call Transcript

Aug 19, 2021 / 12:00PM GMT
Release Date Price: kr10.56 (-5.55%)
Operator

Hello, and welcome to the Medivir AB Q2 Report 2021. (Operator Instructions) Today, I am pleased to present Magnus Christensen, Interim CEO and CFO; and Fredrik Ãberg, CFO. Please begin your meeting.

Magnus Christensen;publ;CFO;Interim CEO
Medivir AB

()-&

Thank you, operator, and welcome to Medivir's Q2 webcast. Please move to Slide 2. Today's presentation will be held by myself, Magnus Christensen, Interim CEO and CFO of Medivir; and Fredrik Ãberg, our Chief Scientific Officer. I am the interim CEO during the recruitment process of the new CEO coming into the company. Next slide, please.

I will not go through this, but recommend you to read it at our homepage, where you can find the presentation as well. Please move to Slide #5.

Here is today's agenda. I will start off with an overview of Medivir, then take you through the financial highlights for quarter 2 and then talk about the remetinostat revenue share agreement that we announced beginning of this week. Then I will hand over to Fredrik

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot